Paving the Way for Biomedical Innovation

The Frederick National Laboratory is meeting the nation’s most urgent biomedical research needs and serves as a national and global resource for the scientific community. 

Comparative analysis adds evidence in favor of one-dose HPV vaccination in girls

An analysis of data from two clinical trials in sub-Saharan Africa, a region with one of the highest cervical cancer rates...

Conference: FNL joins two panels at 2024 BIO International Convention

Partnership development leaders at the Frederick National Laboratory for Cancer Research (FNL) will share their perspectives...
Genetics

New CRISPR screening platform could drive development of next-generation drugs

Scientists at the Frederick National Laboratory for Cancer Research (FNL) and their National Cancer Institute colleagues have...
Cancer Research

RAS Initiative study shines the spotlight on less-understood KRAS4a

A four-year effort undertaken by the NCI RAS Initiative has come to fruition, revealing a host of new information about a...

Clinical Monitoring Research Program to support clinical study exploring alternative to cervical cancer screening

A new U.S. clinical trial will evaluate whether an at-home, self-collection technique to screen for cervical cancer is as...
Cancer Research

RAS Initiative partnership identifies novel therapeutic, improves predominant drug discovery model

A team from the National Cancer Institute RAS Initiative and collaborators at Lawrence Livermore National Laboratory and...
HIV/AIDS Research

Study establishes measurement for factor affecting immune response to HIV

HIV ravages the immune system in people who acquire it, but not everyone is affected equally. In some of these individuals...
What is this?

Representative picture of colon of infected RM- that was infused with engineered CD8+ T cells to reduce the viral load. The Tissue Analysis and Retroviral Protein Core provides state-of-the-art tissue analysis capabilities.

Information

SeroNet

The Serological Sciences Network, or SeroNet, is a collaboration to enhance understanding of the immune response to the novel coronavirus, SARS-CoV-2. SeroNet supports research projects in basic and applied serological research related to COVID-19 and increasing the nation’s serological testing capacity.
170
U.S. SARS-CoV-2 Serology Standard requests from industry, government and academic laboratories worldwide.
Initiative

Scientific Standards Hub

Our scientists establish standards and reference reagents for diverse scientific  disciplines and  encourage the adoption of benchmarks  among researchers. 
8
disciplines with tools to help bridge gaps in scientific reproducibility.

Our Passion is Infectious

Shape Your Career

Work with the best of the best biomedical researchers and investigators. Be a part of groundbreaking solutions that benefit public health throughout the world. And, enjoy some of the best benefits in the region. We are looking for smart, passionate problem solvers for benchwork, data science, manufacturing, and more.